Clinical Trial

Efficacy and Safety Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial is to evaluate the efficacy and safety of Olistic Next Women, a nutraceutical supplement, in women diagnosed with early FPHL.This 6-month, open-label, interventional clinical trial investigates whether daily supplementation with Olistic Next Women leads to significant improvements in hair parameters. The study also monitors the tolerability and safety of the product throughout the intervention.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-10.
Status change: Active, Not Recruiting → Completed 2026-01-09
Trial Details
NCT Number NCT07300228
Lead Sponsor Olistic Research Labs S.L.
Conditions Early Female Pattern Hair Loss (FPHL)
Enrollment 39 participants
Start Date 2024-09-16
Primary Completion 2025-05-20 (estimated)
Study Completion 2025-12-23 (estimated)
Updated on ClinicalTrials.gov 2026-01-12